CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8 T Cells.
Immunity
View this publicationImmunity
View this publicationJournal of nuclear medicine : official publication, Society of Nuclear Medicine
View this publicationEBioMedicine
View this publicationPublication categories: Top publication
Immunity
View this publicationJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
View this publicationClinical epigenetics
View this publicationFrontiers in oncology
View this publicationDermatology and therapy
View this publicationBMC cancer
View this publicationEpigenetics
View this publication